Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Cardiology

Glassworks of Amsterdam has helped develop an extremely accurate, computer-generated simulation of the human heart.
The FDA has approved Cangrelor, an intravenous drug that will be used to prevent blood clots in patients who receive an angioplasty, according to a report from Reuters. Cangrelor was developed by The Medicine Co. and has taken a decade to earn approval...
From 2003 to 2013, the death rate from coronary heart disease, according to a CDC report, has dropped by nearly 40% according to The New York Times. This change, however, is not a result from any new technologies or drugs but instead a combination of...